Bioxyne lifts FY26 guidance after margin growth in strong first half by Steve Jones February 26, 2026February 26, 2026 Shares in medicinal cannabis pastille manufacturer Bioxyne climbed more than 13% today after lifting its FY26 […]
Bioxyne stays on course to hit A$25m revenue guidance despite Q3 fall by Steve Jones April 28, 2025April 28, 2025
MedTEC Pharma plots unique path with locally grown freeze-dried products by Steve Jones February 12, 2025February 13, 2025
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024November 25, 2024
Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix by Steve Jones and Martin Lane January 31, 2024July 11, 2024
